The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Krista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Since its initial public offering, Convatec has followed a familiar playbook to press its advantage in advanced wound care and to enhance its ostomy business. By and large, we like Convatec’s ...

We felt confident he could find a new job with health insurance because the labor market ... At the time, insulin cost about ...

The trial involves islet cell transplants and an innovative anti-rejection drug to help patients produce their own insulin.

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.